Código QR (código de barras bidimensional)

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization

Objective It has been proved that glucagon-like peptide-1 receptor (GLP1R) agonists have positive effects on renal outcomes in diabetic patients. However, it remains unknown whether GLP1R agonists could provide similar protection against other kidney diseases.Methods We performed two-sample Mendelia...

תיאור מלא

שמור ב:
Principais autores: Yu-Xuan Yao, Chen Tang, Feng-Lei Si, Ji-Cheng Lv, Su-Fang Shi, Xu-Jie Zhou, Li-Jun Liu, Hong Zhang
פורמט: Artigo
שפה:Inglês
יצא לאור: Taylor & Francis Group 2025-12-01
סדרה:Renal Failure
נושאים:
Glucagon-like peptide-1 receptor agonists
chronic kidney disease
diabetic nephropathy
IgA nephropathy
Mendelian randomization
גישה מקוונת:https://www.tandfonline.com/doi/10.1080/0886022X.2025.2478488
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים